CTP inhibitor is a highly effective and specific inhibitor of the plasma membrane citrate transporter (PMCT), effectively targeting and inhibiting the transporter responsible for citrate transport. [1]
CTP499, a selective PDE inhibitor, and the deuterium-containing agent is an HDX analogue and a metabolite of hexantheobromine that slows the progression of type 2 diabetic nephropathy in patients with macroalbuminuria.
Cytarabine triphosphate (Ara-CTP), a competitive inhibitor of DNA synthesis and an active metabolite of Cytarabine, exhibits predictive potential for leukemic blasts' chemosensitivity to Cytarabine through intracellular levels.
5-Propargylamino-ddCTP is a nucleoside molecule utilized in the synthesis of cyanine dye-nucleotide conjugate, which finds application in nucleic acid labeling and sequence analysis.
5-Propargylamino-dCTP, also known as dCTP-PA, is a nucleoside molecule. It can form conjugates with molecular markers, enabling its application in nucleic acid labeling and sequence analysis.